Claya Review

Our assessment

Claya sells a membership, and it tells you outright that the medication is billed on top of it. It names both partner pharmacies with street addresses and phone numbers, which almost nobody does, and it puts a brand-name pen and a compounded alternative on the same card so you can see the gap before an intake. Then it publishes two different membership fees on two of its own pages. It says it serves all fifty states and the District of Columbia, then excludes Louisiana from compounded GLP-1s in capitals further down the same document. And every medication figure is an as-low-as number.

The membership is the product, and it says so

Ask most sellers whether the price includes the drug and you get silence. Claya answers in a sentence: the membership fee includes access to reduced-price GLP-1 medications and personalized care coaching, but the medication is not included in the fee. You will, it adds, receive your medications at a steeply discounted price.

That is the clearest statement of a split bill you will find here, and it matters more than it sounds. A membership figure is a fraction of a bill. A flat monthly figure elsewhere is the whole one.

What undermines it is that the fee itself is published twice, at two different amounts. The FAQ on the weight-loss page answers the question with one figure. The treatment card that renders on every single product page shows a lower one. Both were live at the same time. Budget for the higher one.

Two pharmacies, with addresses you can dial

At the foot of the Terms, under a heading reading Partner Pharmacies, there are two entries. Each has a legal name, a street address, a telephone number and a website: one in St. George, Utah, one in Florence, Kentucky. The same block repeats in the site footer on every page.

That is a deep disclosure rather than a broad one. Ondra Health names six with their regulatory classes and Lavender Sky Health names more than a dozen. Tyde Wellness matches Claya on depth and beats it on length, publishing five pharmacies with an address, a telephone number and an email for each. What Claya gives you is two facilities you could check against a state board, or simply call.

Set against that, the Terms also say the company is not acting as a pharmacy, does not control how medication is provided, and does not endorse any specific pharmacy. Ask which of the listed pharmacies will fill your prescription.

The prescribing side is thinner. An our-approach page introduces a medical advisory team of two: a naturopathic doctor specializing in metabolic health, and a cardiologist with a long string of fellowships. The heading calls them experts who support your journey. The Terms describe whoever actually writes your prescription only as licensed physicians, medical providers and other clinicians employed or contracted by unnamed medical groups. An advisory-board listing does not identify the clinician who would review your intake.

A brand pen and a compounded vial on the same card

Every weight-loss page carries the same treatment-and-membership block: a brand-name tirzepatide pen, a compounded semaglutide injection, compounded semaglutide tablets, a brand-name semaglutide pen, a second brand-name tirzepatide pen, and the membership. All six priced, all six on one screen.

That layout puts a four-figure brand price directly beside a three-figure compounded one and lets you draw your own conclusion. Bon Health publishes both too, but its brand page is badged Coming Soon. Here both routes have live start buttons.

Claya is also careful in a way worth crediting. Beneath the trial statistics on every product page it prints a line saying those studies evaluated the manufacturer-developed, FDA-approved products and did not assess compounded semaglutide or compounded tirzepatide. Sellers borrow brand trial numbers for compounded products all the time without saying that.

Less careful: the compounded semaglutide card describes the product as having the same active ingredient as Ozempic and Wegovy. The FDA quoted that exact construction in a September 2025 warning letter to Lovely Meds, also reviewed here, saying it implies a compounded product is the same as an FDA-approved one when it is not. The FDA's warning-letter database was searched under this company's legal entity and its brand name, and neither returned a letter. That is a point about the wording, not an accusation about this seller.

Fifty states, then forty-nine

The Terms open by saying the site and services are available in all fifty states plus the District of Columbia. Further down the same document, in capital letters, they say that because of Louisiana law the third-party partner pharmacies cannot provide compounded GLP-1 medications to residents of Louisiana.

Both statements are true of different things: the platform is available everywhere, the compounded drugs are not. But a reader in Louisiana meets the fifty-state claim first and the exclusion only if they read the Terms to the end. If you live in Louisiana and you came for a compounded GLP-1, this seller cannot supply you.

One more thing in the same footer: the copyright line reads Copyright, the symbol, and then the literal word year in square brackets. It is an unfilled template token, and it renders on the terms page, the weight-loss page and every product page.

What as low as is hiding

Not one medication figure on this site is a settled price. Every card says as low as, and none states a dose, a quantity, a vial size or a plan length beside the number. The compounded semaglutide figure could be the starting dose or the maintenance dose, a month's supply or a first fill.

For the brand-name products, request a quote for the exact medication, strength, supply and payment route. An as-low-as price does not establish your total, and a lower strength is not necessarily cheaper.

The first-month promotion is published as an amount off with a coupon code, never as a resulting price. Subtract a coupon from an as-low-as figure and you get a number this seller has never printed.

The company behind all of this is Scrappy Scripts, Inc., a Delaware corporation doing business as Claya.com, named in the first sentence of the Terms. Brand name and legal name share nothing, which is worth knowing if you ever need to look the company up.